TRANSVAC research infrastructure - Results and lessons learned from the European network of vaccine research and development

Vaccine. 2015 Oct 5;33(41):5481-5487. doi: 10.1016/j.vaccine.2015.01.079. Epub 2015 Feb 8.


TRANSVAC was a collaborative infrastructure project aimed at enhancing European translational vaccine research and training. The objective of this four year project (2009-2013), funded under the European Commission's (EC) seventh framework programme (FP7), was to support European collaboration in the vaccine field, principally through the provision of transnational access (TNA) to critical vaccine research and development (R&D) infrastructures, as well as by improving and harmonising the services provided by these infrastructures through joint research activities (JRA). The project successfully provided all available services to advance 29 projects and, through engaging all vaccine stakeholders, successfully laid down the blueprint for the implementation of a permanent research infrastructure for early vaccine R&D in Europe.

Keywords: Adjuvants; Animal Models; Biomarkers; European Research Infrastructures; FP7; Harmonisation; Research and Development; Services; Standardisation; Vaccine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biotechnology
  • Europe
  • Humans
  • International Agencies*
  • International Cooperation*
  • Research*
  • Vaccines*


  • Vaccines